Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) investors are running for the hills, after the drug announced that its shares will be delisted from the NASDAQ Stock …
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) announced that the U.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) and KemPharm, Inc.
Acura Pharmaceuticals, Inc (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from cohort 2 of clinical study AP-LTX-400 …
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the first quarter ended March 31, 2016.
Healthcare analysts commented on Clovis Oncology Inc (NASDAQ:CLVS) and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) following an FDA Committee decision and an FDA Fast Track designation, respectively.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that clinical testing of its lead LIMITX™ oral abuse deterrent …
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the …
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), announced the receipt of a $2.